Gilead Sciences, Inc. 13D and 13G filings for HOOKIPA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-22 4:18 pm Purchase | 2023-12-20 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 1,875,947 19.400% | 1,500,000 (+398.99%) | Filing |
| 2023-02-14 2:06 pm Unchanged | 2022-03-24 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 375,947 7.200% | 0 (Unchanged) | Filing |
| 2022-02-17 2:43 pm Purchase | 2022-02-15 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 375,947 12.900% | 166,667 (+79.64%) | Filing |
| 2021-02-12 4:36 pm Purchase | 2020-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 209,280 7.200% | 42,553 (+25.52%) | Filing |
| 2020-02-14 1:14 pm Unchanged | 2019-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 166,727 7.700% | 0 (Unchanged) | Filing |